Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis.

Bell, Christopher F; Wu, Benjamin; Huang, Shirley P; Rubin, Bernard; Averell, Carlyne M; Chastek, Benjamin; Hulbert, Erin M; Von Feldt, Joan

Bell, Christopher F; Wu, Benjamin; Huang, Shirley P; Rubin, Bernard; Averell, Carlyne M; Chastek, Benjamin; Hulbert, Erin M; Von Feldt, Joan.

Afiliación

Bell CF; US Value, Evidence and Outcomes, GSK, Durham, USA.
Wu B; US Value, Evidence and Outcomes, GSK, Durham, USA.
Huang SP; US Value, Evidence and Outcomes, GSK, Durham, USA.
Rubin B; US Medical Affairs, GSK, Durham, USA.
Averell CM; US Value, Evidence and Outcomes, GSK, Durham, USA.
Chastek B; Life Sciences, Health Economics and Outcomes Research (HEOR), Optum, Eden Prairie, USA.
Hulbert EM; Life Sciences, Health Economics and Outcomes Research (HEOR), Optum, Eden Prairie, USA.
Von Feldt J; US Medical Affairs, GSK, Philadelphia, USA.

Cureus ; 15(4): e37839, 2023 Apr.

Article en En | MEDLINE | ID: mdl-37214060

Palabras clave

healthcare costs; healthcare resource utilization; lupus nephritis; nephritis; renal lupus; systemic lupus erythematosus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Health_economic_evaluation / Observational_studies / Risk_factors_studies Aspecto: Implementation_research Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google